A Phase 3 Study Of Enasidenib (Ena) Versus Conventional Care Regimens (Ccr) In Older Patients With Late-Stage Mutant-Idh2 (Midh2) Relapsed/Refractory Acute Myeloid Leukemia (R/R Aml)
Enasidenib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 3 Study Of Enasidenib (Ena) Versus Conventional Care Regimens (Ccr) In Older Patients With Late-Stage Mutant-Idh2 (Midh2) Relapsed/Refractory Acute Myeloid Leukemia (R/R Aml) ### Output: Enasidenib